Founded in 1924, BIAL’s mission is to discover, develop and provide new therapeutic solutions within the area of Health. In recent decades, BIAL has strategically focused on quality, innovation, and internationalisation.
Strongly committed to therapeutic innovation, BIAL invests more than 20 per cent of its annual turnover in Research and Development (R&D), centered on the neurosciences and cardiovascular system. The investment in internationalization is another of BIAL& main operating guidelines whose products are in pharmacies of more than 55 countries spread over 4 continents: Europe, America, Africa and Asia.
Currently, BIAL is strengthening its international presence, namely in the most relevant European pharmaceutical markets such as Spain, Germany, United Kingdom and Italy, where BIAL has its own affiliates. BIAL has also offices in Switzerland, Mozambique, Ivory Coast, Angola and Panama. The company expects to introduce more new medicines to the market in the next years, strengthening its international presence based in its own innovative medicines and accomplishing the purpose of delivering innovative products to patients worldwide.

ETICOS since 1984, the Paraguayan company manufactures cutting-edge pharmaceutical products, incorporating scientific and technological innovations with the main purpose of meeting the needs of doctors and patients by offering medicines manufactured under the most rigorous international pharmaceutical guidelines (FDA/EMEA) contributing everyday with the improvement of healthcare by offering people, safe, efficient and trustworthy medicine
Oftalmica was founded in 1986 as an answer to the ophthalmologists´ needs of specific medication with high quality standards which were accessible for the patients.

AMOMED PHARMA GmbH is an international, emerging and opportunity-driven specialty company based in Vienna, Austria. Since our establishment in 2006, it has grown into a renowned specialist for intensive care and emergency medicine, anesthesia and neuro-psychiatric products. their goal is to position AMOMED as Europe's leading player in anesthesia and intensive care medicine over the next few years.
They are an independent and privately-owned company; their first obligation is to ensure the success of a patient’s medical treatment. To this end, it maintains close ties with medical science, yet place a strong emphasis on practical use. This makes them a sought-after partner for doctors, specialists and decision-makers.
They are both an expert distribution partner for hospitals and a valuable partner for medical specialists, dedicated to providing the solutions they need. their products comprise the medication needed in critical, life-threatening situations.
Highest quality standards, delivery reliability and a strong drive for excellence as a team are fundamentally important to them. They act swiftly and flexibly to find the right solutions – in close consultation with medical specialists and for the benefit of patients. They share the responsibility for the smooth functioning of medical measures at the decisive moment. At AMOMED they are fully aware of the importance of their actions and are deeply committed to the far-reaching aspect of their work. They  put our motto into practice each day:
AMOMED – Medicine when it matters most.